Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical TrialAndrew Ahmann, Vanita R. Aroda, Elena Henkel et al.|Diabetes Care|2017Cited by 574
The relationship between serum potassium concentrations and electrocardiographic characteristics in 163,547 individuals from primary careMaria Lukács Krogager, Steen Møller Hansen, Kristian Kragholm et al.|Journal of Electrocardiology|2019Cited by 22